Harmony Biosciences Holdings Inc (HRMY)
34.07
+0.84
(+2.53%)
USD |
NASDAQ |
Nov 22, 16:00
34.07
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Price to Book Value: 3.256 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 3.256 |
| November 21, 2024 | 3.176 |
| November 20, 2024 | 3.134 |
| November 19, 2024 | 3.104 |
| November 18, 2024 | 3.160 |
| November 15, 2024 | 3.174 |
| November 14, 2024 | 3.154 |
| November 13, 2024 | 3.234 |
| November 12, 2024 | 3.352 |
| November 11, 2024 | 3.432 |
| November 08, 2024 | 3.448 |
| November 07, 2024 | 3.336 |
| November 06, 2024 | 3.277 |
| November 05, 2024 | 3.193 |
| November 04, 2024 | 3.158 |
| November 01, 2024 | 3.161 |
| October 31, 2024 | 3.070 |
| October 30, 2024 | 3.23 |
| October 29, 2024 | 3.965 |
| October 28, 2024 | 3.416 |
| October 25, 2024 | 3.297 |
| October 24, 2024 | 3.254 |
| October 23, 2024 | 3.254 |
| October 22, 2024 | 3.331 |
| October 21, 2024 | 3.340 |
| Date | Value |
|---|---|
| October 18, 2024 | 3.384 |
| October 17, 2024 | 3.342 |
| October 16, 2024 | 3.329 |
| October 15, 2024 | 3.392 |
| October 14, 2024 | 3.390 |
| October 11, 2024 | 3.328 |
| October 10, 2024 | 3.326 |
| October 09, 2024 | 3.211 |
| October 08, 2024 | 3.321 |
| October 07, 2024 | 3.285 |
| October 04, 2024 | 3.306 |
| October 03, 2024 | 3.323 |
| October 02, 2024 | 3.399 |
| October 01, 2024 | 3.750 |
| September 30, 2024 | 3.822 |
| September 27, 2024 | 4.129 |
| September 26, 2024 | 4.199 |
| September 25, 2024 | 3.935 |
| September 24, 2024 | 3.991 |
| September 23, 2024 | 4.036 |
| September 20, 2024 | 4.146 |
| September 19, 2024 | 4.114 |
| September 18, 2024 | 4.046 |
| September 17, 2024 | 4.096 |
| September 16, 2024 | 4.090 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.336
Minimum
Oct 27 2023
30.89
Maximum
Nov 10 2020
10.18
Average
9.880
Median
Nov 21 2022
Price to Book Value Benchmarks
| Regeneron Pharmaceuticals Inc | 2.765 |
| Incyte Corp | 4.357 |
| EyePoint Pharmaceuticals Inc | 2.793 |
| Cassava Sciences Inc | 7.645 |
| Capricor Therapeutics Inc | 12.40 |
Price to Book Value Related Metrics
| PE Ratio | 16.15 |
| PS Ratio | 2.899 |
| Price to Free Cash Flow | 8.977 |
| Price | 34.07 |
| Earnings Yield | 6.19% |
| Market Cap | 1.943B |
| Operating PE Ratio | 11.28 |
| Normalized PE Ratio | 16.15 |